Volume 12, Number 3 (Apr 2021)

Editorial

JADPRO Live Virtual 2020: Learning Today, Leading Tomorrow

In this special issue of JADPRO, we highlight important takeaways for advanced practitioners from the educational sessions presented at our annual meeting, JADPRO Live.  

April 19, 2021

Meeting Report

Advanced Practitioner Leadership in Times of Crisis

JADPRO Live Virtual kicked off with the opening panel on advanced practitioner leadership during the COVID-19 pandemic. The group discussed their institutional emergency protocols, how they leveraged advanced practitioners (APs) to provi...

April 19, 2021

Meeting Report

Words Matter: Use of Respectful Language in Oncology

During JADPRO Live Virtual 2020, Conference Chair Laura J. Zitella, MS, RN, ACNP-BC, AOCN®, spoke with Tatiana M. Prowell, MD, about overcoming implicit bias, the power of language, and creating a culture of respect in oncology for both ...

April 19, 2021

Meeting Report

Are Current Metrics Adequate to Demonstrate the Value of Oncology Advanced Practitioners?

At JADPRO Live Virtual 2020, Jason Astrin, DMSc, MBA, PA-C, DFAAPA, defined the concepts of productivity and value and discussed strategies for measuring the value of oncology advanced practitioners in order to recognize advanced practit...

April 19, 2021

Meeting Report

The Elevator Pitch: Communicating Your Expertise, Experience, and Value to Patients, Co-Workers, and Prospective Employers in an Instant

During JADPRO Live Virtual 2020, Andrew S. Guinigundo, MSN, RN, CNP, ANP-BC, provided guidance to advanced practitioners on creating their elevator pitch and communicating their role. 

April 19, 2021

Meeting Report

Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer

Cardio-oncology is a rapidly emerging field, and advanced practitioners (APs) play key roles in the prevention, early detection, and optimal treatment of cardiotoxicities associated with cancer therapies. At JADPRO Live Virtual 2020, Jes...

April 19, 2021

Meeting Report

Management of Diabetes in the Patient With Cancer

During JADPRO Live Virtual 2020, Lorena A. Wright, MD, FACE, reviewed the principles of antihyperglycemic management and discussed the importance of working as a team to collaborate in the management of patients with cancer.

April 19, 2021

Meeting Report

Sticky Issues: What APs Need to Know About Anticoagulants and Patients With Cancer

During the JADPRO Live Virtual 2020 conference, Val R. Adams, PharmD, FCCP, FHOPA, BCOP, discussed how to determine which patients with cancer should be treated with direct oral anticoagulants (DOACs), the similarities and differences be...

April 20, 2021

Meeting Report

Approach to the Hospitalized Patient With Thrombocytopenia

During the 2020 JADPRO Live Virtual conference, Laura J. Zitella, MS, RN, ACNP-BC, AOCN®, educated the audience on the most important causes of thrombocytopenia in hospitalized patients and diagnostic approaches to employ. 

April 20, 2021

Meeting Report

Mitigating the Morbidity of Financial Toxicity in Cancer Care

At JADPRO Live Virtual 2020, Veena Shankaran, MD, MS, reviewed data around the prevalence and risk factors for financial toxicity, discussed potential downstream consequences of financial toxicity in cancer care, and outlined four key st...

April 20, 2021

Meeting Report

2019–2020 Drug Updates in Solid Tumors

During JADPRO Live Virtual 2020, Kirollos S. Hanna, PharmD, BCPS, BCOP, updated the audience on the pharmacology, new indications, and the clinical trial data of novel medications as well as expanded indications in solid tumors. Dr. Hann...

April 20, 2021

Meeting Report

2019–2020 Drug Updates in Hematologic Malignancies

During JADPRO Live Virtual 2020, Heidi D. Finnes, PharmD, BCOP, FHOPA, discussed the pharmacology and indications of medications approved from late 2019 to late 2020 for the management of patients with hematologic malignancies, reviewed ...

April 20, 2021

Meeting Report

Biomarker Jeopardy

The popular Biomarker Jeopardy session returned this year at JADPRO Live 2020. Sandra E. Kurtin, PhD, ANP-C, AOCN®, led the session, and was joined by Alyssa Henglefelt, PharmD, BCOP, and Allyson Price, PA-C. Using a Jeopardy format, the...

April 20, 2021

Meeting Report

Immune Checkpoint Inhibitors: Common Questions About Uncommon Adverse Events

At JADPRO Live Virtual 2020, Lisa Kottschade, APRN, MSN, CNP, highlighted considerations for advanced practitioners on the recognition and monitoring of rare and life-threatening immune-related adverse events (irAEs), as well as strategi...

April 20, 2021

Meeting Report

FDA and Its Role in Drug Development

JADPRO Live 2020 was honored to have Dr. Richard Pazdur, the Director of the Oncology Center of Excellence at the FDA, discuss recent changes to oncology drug development and the approval process, the roles of the advanced practitioner i...

April 20, 2021

Meeting Report

Advanced Prostate Cancer: Considerations for Advanced Practitioners

At JADPRO Live Virtual 2020, Brenda Martone, MSN, ANP-BC, AOCNP®, discussed treatment options available for advanced prostate cancer patients and the role of genetics and genomics in patients with advanced prostate cancer. 

April 20, 2021

Meeting Report

The Landscape of the Advanced NSCLC Treatment Paradigm: Molecular Testing and Actionable Mutations

At JADPRO Live Virtual 2020, Rasheda Persinger, AGNP-C, explained the current lung cancer treatment landscape, including targeted therapies for EGFR and ALK rearrangements, as well as for BRAF, ROS1, NTRK, RET, MET, and KRAS mutations, a...

April 21, 2021

Meeting Report

A Multidisciplinary Approach to Head and Neck Cancer

At JADPRO Live Virtual 2020, Casey Fazer-Posorske, PA-C, provided updates in the management of patients with head and neck cancer, including the types of head and neck cancers, their associated treatments and side-effect management, the ...

April 21, 2021

Meeting Report

Developments in Hepatocellular Cancer Treatment

The treatment landscape of hepatocellular cancer has changed significantly within the past few years. At JADPRO Live Virtual 2020, Bridget O’Brien, DNP, APRN, FNP-BC, AOCNP®, provided an overview of developments in hepatocellular cancer ...

April 21, 2021

Meeting Report

Infrequent Offenders: Neuroendocrine Tumors and Cancers of the Appendix, Gallbladder, and Bile Duct

During JADPRO Live Virtual 2020, Kristen O’Hagan, ANP-BC, MS, AOCNP®, provided an overview of rare gastrointestinal tumors, their presentation, and current treatment algorithms. Ms. O’Hagan also discussed the advanced practitioner’s role...

April 21, 2021

Meeting Report

Kidney Cancer Combinations: Tracking and Treating Symptoms With the Challenge of Combination Therapy

At JADPRO Live Virtual 2020, Kathleen Burns, AGACNP-BC, OCN®, discussed strategies to track and treat symptoms associated with combination therapies for the treatment of renal cell carcinoma. 

April 21, 2021

Meeting Report

Sarcoma: Disease Overview and Treatment Updates

During JADPRO Live Virtual 2020, Cissimol Joseph, APRN, AOCNP®, and Prachee Singh, PA-C, MS, highlighted the clinical features and diagnostic workup of soft-tissue sarcoma and presented on a multidisciplinary approach to treatment planni...

April 21, 2021

Meeting Report

Optimizing Treatment of Chronic Lymphocytic Leukemia

During JADPRO Live Virtual 2020, Sandra Kurtin, PhD, ANP-C, AOCN®, described personalization of the treatment of chronic lymphocytic leukemia (CLL) using molecular attributes of the disease, as well as patient characteristics. Dr. Kurtin...

April 21, 2021

Meeting Report

Diagnosis and Treatment of AL and ATTR Amyloidosis

At JADPRO Live Virtual 2020, Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN, and Tiffany Richards, PhD, ANP-BC, AOCNP®, differentiated between AL and ATTR amyloidosis, discussed key considerations in selecting therapy, and identified wa...

April 21, 2021

Meeting Report

Improving Outcomes in Hematopoietic Stem Cell Transplant: Recent Advances

During JADPRO Live Virtual 2020, Maritza Alencar, DNP, MBA, APRN-BC, BMTCN, described advances in the management and prevention of infectious disease complications and graft-vs.-host disease following transplant. Dr. Alencar also emphasi...

April 21, 2021

Meeting Report

Hemolytic Anemias: Autoimmune and Beyond

During JADPRO Live Virtual 2020, Ravi Krishnadasan, MD, FACP, provided an overview of the terminology of hemolysis, laboratory tests used in the diagnosis of hemolytic anemias, and appropriate indications for treatment of the various hem...

April 21, 2021